Table 4. Clinical findings in transplant... | American Society of Hematology

Table 4.

Clinical findings in transplant recipients with measles

Patient no.	Age	BMT type	Time after BMT	GVHD at evaluation	GVHD treatment	Serologic status	Duration of rash	Koplik spots	Fever cough	IgM	IVIg	Complication
1	42	Allo	3 y 9 m	CL	None	Neg	7 d	No	Yes	Pos	Yes	None
2	28	Allo	6 y 9 m	No	None	Neg	12 d	Yes	Yes	Pos	No	None
3	25	Allo	3 y 1 m	No	None	<100 mIU/mL	5 d	No	No	Pos	No	None
4	17	Allo	4 y 10 m	No	None	Neg	6 d	Yes	Yes	Pos	No	None
5	45	Allo	4 y 9 m	No	None	Neg	10 d	Yes	Yes	Neg	Yes	None
6	27	Allo	Day +373	CE	CyA/PDN	Neg	18 h	Yes	Yes	Pos	Yes	MIP
7	10	Allo	Day +257	No	CyA	100 mIU/mL	7 d	No	Yes	Pos	Yes	None
8	38	Allo	6 y 7 m	No	None	Not done	6 d	Yes	Yes	Neg	No	None

Patient no.	Age	BMT type	Time after BMT	GVHD at evaluation	GVHD treatment	Serologic status	Duration of rash	Koplik spots	Fever cough	IgM	IVIg	Complication
1	42	Allo	3 y 9 m	CL	None	Neg	7 d	No	Yes	Pos	Yes	None
2	28	Allo	6 y 9 m	No	None	Neg	12 d	Yes	Yes	Pos	No	None
3	25	Allo	3 y 1 m	No	None	<100 mIU/mL	5 d	No	No	Pos	No	None
4	17	Allo	4 y 10 m	No	None	Neg	6 d	Yes	Yes	Pos	No	None
5	45	Allo	4 y 9 m	No	None	Neg	10 d	Yes	Yes	Neg	Yes	None
6	27	Allo	Day +373	CE	CyA/PDN	Neg	18 h	Yes	Yes	Pos	Yes	MIP
7	10	Allo	Day +257	No	CyA	100 mIU/mL	7 d	No	Yes	Pos	Yes	None
8	38	Allo	6 y 7 m	No	None	Not done	6 d	Yes	Yes	Neg	No	None

Allo indicates allogeneic; CL, chronic limited; CE, chronic extensive; MIP, measles interstitial pneumonia; CyA, cyclosporin A; PDN, prednisone; Pos, positive; and Neg, negative.